MedWatch

Here is Novo Nordisk’s strategy for the future

Novo Nordisk has made a plan for the future growth in different branches of the business. The plan includes focus on the traditional core as well as new areas. Moreover, the Danish company has intensified the pursuit of possible acquisitions.

Foto: /ritzau/Stine Tidsvilde

The search for future growth opportunities takes the Danish drug group Novo Nordisk in new directions. The company extends its focus to serious chronic diseases related to the core focus on diabetes and obesity.

However, this does not mean a complete turn-away from the core business or the smaller biopharma business that for instance includes growth hormones and drugs against hemophilia.

Læs hele artiklen

Få 14 dages fri adgang.
Det kræver intet kreditkort.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Relaterede

Seneste nyt

Ledige job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier